Cargando…
S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428313/ http://dx.doi.org/10.1097/01.HS9.0000967444.46240.9a |
| _version_ | 1785090437908791296 |
|---|---|
| author | Gill, Harry Yim, Rita Chin, Lynn Lee, Paul LI, Vivian Au, Lester Kit Garret Leung, Man Kumana, Cyrus Lam Kwong, Yok |
| author_facet | Gill, Harry Yim, Rita Chin, Lynn Lee, Paul LI, Vivian Au, Lester Kit Garret Leung, Man Kumana, Cyrus Lam Kwong, Yok |
| author_sort | Gill, Harry |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428313 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283132023-08-17 S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION Gill, Harry Yim, Rita Chin, Lynn Lee, Paul LI, Vivian Au, Lester Kit Garret Leung, Man Kumana, Cyrus Lam Kwong, Yok Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428313/ http://dx.doi.org/10.1097/01.HS9.0000967444.46240.9a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Gill, Harry Yim, Rita Chin, Lynn Lee, Paul LI, Vivian Au, Lester Kit Garret Leung, Man Kumana, Cyrus Lam Kwong, Yok S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION |
| title | S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION |
| title_full | S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION |
| title_fullStr | S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION |
| title_full_unstemmed | S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION |
| title_short | S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION |
| title_sort | s133: an entirely oral regimen of oral-ato, atra and ascorbic acid in risk-adapted treatment of newly-diagnosed apl resulted in excellent clinical/molecular responses with durable remission |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428313/ http://dx.doi.org/10.1097/01.HS9.0000967444.46240.9a |
| work_keys_str_mv | AT gillharry s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT yimrita s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT chinlynn s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT leepaul s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT livivian s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT aulester s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT kitgarretleungman s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT kumanacyrus s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission AT lamkwongyok s133anentirelyoralregimenoforalatoatraandascorbicacidinriskadaptedtreatmentofnewlydiagnosedaplresultedinexcellentclinicalmolecularresponseswithdurableremission |